AI Is Flooding Drug Discovery With Candidates. Clinical Validation Has No Flood Gates.
AI can generate 100x more drug candidates, but trials still need real patients. The bottleneck has shifted, and most...
AI can generate 100x more drug candidates, but trials still need real patients. The bottleneck has shifted, and most...
Six AI models picked the same "random" number. Clinical ops leaders are finally asking what that reveals about every...
Of 117 AI-enabled drug assets tracked in clinical trials, only 8 have cleared Phase II. Speed is real. Efficacy...
AI drug discovery raised $8.9B in 2024, yet no AI-discovered drug holds FDA approval. The gap between algorithmic promise...
Healx's HLX-4310 Phase 1/2 trial in osteosarcoma shows AI drug discovery maturing—but adaptive dose-escalation in adolescent oncology exposes trial...
$7B committed to AI drug discovery, zero approved drugs. The real bottleneck is clinical development—and the capital hasn't caught...